Publications

Anticoagulation therapy: Enoxaparin dosing for VTE during pregnancy
Roberts A. Nature reviews. Cardiology. Oct 2013;10(10):552-553.

Population pharmacokinetics of enoxaparin during the antenatal period
Patel JP, Green B, Patel RK, Marsh MS, Davies JG, Arya R. Circulation. September 24, 2013 2013;128(13):1462-1469.
doi:10.1161/circulationaha.113.003198

Roberts LN, Porter G, Barker RD, Yorke R, Bonner L, Patel RK, Arya R.
Chest. 2013 May 16. doi: 10.1378/chest.13-0267
 

Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.
Barsam SJ, Patel R, Arya R.
Br J Haematol. 2013 Apr 5. doi: 10.1111/bjh.12314.

 

Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis.
Roberts LN, Patel RK, Chitongo PB, Bonner L, Arya R.
Br J Haematol. 2013 Mar;160(6):817-24.

 

African-Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation.
Roberts LN, Patel RK, Chitongo P, Bonner L, Arya R.
Blood Coagul Fibrinolysis. 2013 Jan;24(1):40-9.

 

Women's views on and adherence to low-molecular-weight heparin therapy during pregnancy and the puerperium.
Patel JP, Auyeung V, Patel RK, Marsh MS, Green B, Arya R, Davies JG.
J Thromb Haemost. 2012 Dec;10(12):2526-34.

 

Pregnancy loss and thrombophilia: the elusive link.
Bennett SA, Bagot CN, Arya R.
Br J Haematol. 2012 Jun;157(5):529-42.

 

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal.
Patel JP, Green B, Patel RK, Davies JG, Arya R.
J Thromb Haemost. 2012 Mar;10(3):500-2; author reply 502-4.

 

Deep vein thrombosis and pulmonary embolism: diagnosis, treatment and prevention.
Roberts LN, Arya R.
Clin Med. 2011 Oct;11(5):465-6.

 

Anticoagulating obese patients in the modern era.
Patel JP, Roberts LN, Arya R.
Br J Haematol. 2011 Oct;155(2):137-49.

 

How I manage venous thromboembolism in pregnancy.
Arya R.
Br J Haematol. 2011 Jun;153(6):698-708.

 

Prophylaxis with low-dose low molecular weight heparin during pregnancy and the puerperium: is it effective? A rebuttal.
Patel JP, Patel RK, Davies JG, Arya R.
J Thromb Haemost. 2011 Jun;9(6):1269-71; author reply 1272-3.

 

The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy.
Bagot CN, Marsh MS, Whitehead M, Sherwood R, Roberts L, Patel RK, Arya R.
J Thromb Haemost. 2010 Aug;8(8):1736-44.

 

Haemostasis and thrombosis in liver disease.
Roberts LN, Patel RK, Arya R.
Br J Haematol. 2010 Feb;148(4):507-21.

 

Venous thromboembolism and ethnicity.
Roberts LN, Patel RK, Arya R.
Br J Haematol. 2009 Aug;146(4):369-83.

 

New anticoagulants for prevention and treatment of venous thromboembolism.
Roberts LN, Arya R.
Curr Vasc Pharmacol. 2010 May;8(3):373-82.

 

Late onset hypogonadism: an alternate cause for night sweats in the haematology clinic.
Roberts LN, Bagot CN, Patel RK, Whitehead M, Arya R.
Br J Haematol. 2009 May;145(3):435-7.

 

Recurrent refractory arterial thromboembolism associated with the Janus kinase 2 V617F mutation.
Ali FR, Roberts LN, Mistry H, Patel RK, Edmondson RA, Arya R.
J Vasc Surg. 2009 Jan;49(1):211-3.